UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000019876
Receipt No. R000022954
Scientific Title A phase I/II study for the safety and efficacy of Panitumumab in combination with TAS-102 for patients with RAS wild-type metastatic colorectal cancer refractory to standard chemotherapy
Date of disclosure of the study information 2015/11/20
Last modified on 2017/11/21 19:06:31

No. Disposal Last modified on Item of update
1 Insert 2015/11/20 16:51:50
2 Update 2015/12/03 18:02:43 Secondary IDs
Study ID_1
Org. issuing International ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
Org. issuing International ID_2
3 Update 2015/12/03 18:03:17 Recruitment status
4 Update 2015/12/03 18:05:41 Acronym
Acronym
5 Update 2015/12/03 18:07:50 Acronym
Acronym
6 Update 2015/12/03 18:11:40 Primary outcomes
Primary outcomes
Key secondary outcomes
7 Update 2016/09/12 09:06:05 Name of primary sponsor
Organization
8 Update 2017/04/07 12:54:07 Recruitment status
9 Update 2017/04/07 13:04:42 Organization
Organization
Division name
Division name
Address
Address
10 Update 2017/11/21 19:06:31 Address


Contact us.